• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮黏液水肿血清可增加真皮成纤维细胞的增殖,但不增加其糖胺聚糖的合成。

Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts.

作者信息

Ferrarini M, Helfrich D J, Walker E R, Medsger T A, Whiteside T L

机构信息

Department of Pathology, University of Pittsburgh School of Medicine, PA.

出版信息

J Rheumatol. 1989 Jun;16(6):837-41.

PMID:2778769
Abstract

In comparison to normal fibroblasts cultured in parallel, scleromyxedema fibroblasts grew less well, synthesized increased amounts of glycosaminoglycans (GAG) in vitro and had ultrastructural abnormalities. Serum obtained from a patient with scleromyxedema increased in vitro fibroblast proliferation but not the GAG synthesis per cell. Serum obtained after therapy, at the time when clinical improvement was observed, continued to stimulate fibroblast proliferation. Thus the serum factor stimulating the fibroblast proliferation did not modulate their GAG synthesis and had no direct relationship to disease activity.

摘要

与平行培养的正常成纤维细胞相比,硬皮病黏液水肿型成纤维细胞生长较差,在体外合成的糖胺聚糖(GAG)量增加,且存在超微结构异常。硬皮病黏液水肿型患者的血清在体外可增加成纤维细胞增殖,但不增加单个细胞的GAG合成。在观察到临床改善时,治疗后获得的血清继续刺激成纤维细胞增殖。因此,刺激成纤维细胞增殖的血清因子并未调节其GAG合成,且与疾病活动无直接关系。

相似文献

1
Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts.硬皮黏液水肿血清可增加真皮成纤维细胞的增殖,但不增加其糖胺聚糖的合成。
J Rheumatol. 1989 Jun;16(6):837-41.
2
Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.进行性系统性硬化症(PSS,硬皮病)的真皮成纤维细胞合成的糖胺聚糖量增加。
J Lab Clin Med. 1983 May;101(5):659-69.
3
Pretibial myxoedema: stimulation of mucopolysaccharide production of fibroblasts by serum.
Br J Dermatol. 1979 Nov;101(5):557-60.
4
Differential responses of collagen and glycosaminoglycan syntheses and cell proliferation to exogenous transforming growth factor beta 1 in the developing mouse skin fibroblasts in culture.
Br J Plast Surg. 1999 Oct;52(7):579-82. doi: 10.1054/bjps.1999.3163.
5
The acquired cutaneous mucinoses.
Arch Intern Med. 1984 Oct;144(10):1974-80.
6
Human tumor cells in culture stimulate glycosaminoglycan synthesis by human skin fibroblasts.培养中的人类肿瘤细胞可刺激人类皮肤成纤维细胞合成糖胺聚糖。
Lab Invest. 1985 Jul;53(1):30-6.
7
Alterations in scleroderma fibroblast surface glycoproteins associated with increased collagen synthesis.
Acta Derm Venereol. 1987;67(3):199-205.
8
Effect of scleroderma serum on human fibroblast collagen production: possible selection through proliferation.硬皮病血清对人成纤维细胞胶原蛋白生成的影响:可能通过增殖进行选择。
J Rheumatol. 1986 Feb;13(1):99-102.
9
Effect of activated human mast cells and mast cell-derived mediators on proliferation, type I collagen production and glycosaminoglycans synthesis by human dermal fibroblasts.
Eur J Dermatol. 2002 Jul-Aug;12(4):340-6.
10
Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin.己酮可可碱可抑制源自瘢痕疙瘩、硬皮病和局限性硬皮病皮肤的人成纤维细胞的增殖及其胶原蛋白、糖胺聚糖和纤连蛋白的生成。
Br J Dermatol. 1990 Sep;123(3):339-46. doi: 10.1111/j.1365-2133.1990.tb06294.x.

引用本文的文献

1
Intravenous immunoglobulin in the treatment of scleromyxedema associated with monoclonal gammopathy.静脉注射免疫球蛋白治疗与单克隆丙种球蛋白病相关的硬化性黏液水肿
An Bras Dermatol. 2025 Jul-Aug;100(4):501149. doi: 10.1016/j.abd.2025.501149. Epub 2025 Jul 8.
2
Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives.外用芦可替尼在皮肤科的超说明书用药:系统文献综述与当前观点
Exp Dermatol. 2025 Apr;34(4):e70095. doi: 10.1111/exd.70095.
3
Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin.
外用芦可替尼、氨苯砜及静脉注射免疫球蛋白成功治疗硬肿病性黏液水肿的肉芽肿变体。
JAAD Case Rep. 2023 Nov 1;42:78-83. doi: 10.1016/j.jdcr.2023.10.010. eCollection 2023 Dec.
4
Scleroderma Mimickers.硬皮病模仿者
Curr Treatm Opt Rheumatol. 2016 Mar;2(1):69-84. doi: 10.1007/s40674-016-0038-7. Epub 2016 Feb 5.
5
[Differential diagnose of angioedema. Acute edematous scleromyxedema].[血管性水肿的鉴别诊断。急性水肿性硬化性黏液水肿]
Hautarzt. 2014 May;65(5):454-7. doi: 10.1007/s00105-013-2724-9.
6
[Scleromyxedema. A chronic progressive systemic disease].[硬化性黏液水肿。一种慢性进行性全身性疾病]
Z Rheumatol. 2012 Aug;71(6):504-14. doi: 10.1007/s00393-012-0997-5.
7
Scleroderma-like fibrosing disorders.硬皮病样纤维化疾病
Rheum Dis Clin North Am. 2008 Feb;34(1):199-220; ix. doi: 10.1016/j.rdc.2007.11.001.